| Literature DB >> 32108980 |
Satoshi Ishihara1,2, Yuji Okamoto1, Hajime Tanabe1, Akiko Yoshimura1, Yujiro Higuchi1, Jun-Hui Yuan1, Akihiro Hashiguchi1, Hiroyuki Ishiura3, Jun Mitsui3, Shugo Suwazono4, Yasushi Oya5, Masayuki Sasaki6, Masanori Nakagawa7, Shoji Tsuji3, Yusuke Ohya2, Hiroshi Takashima1.
Abstract
Heterozygous mutations in the Berardinelli-Seip congenital lipodystrophy 2 (BSCL2) gene have been reported with different clinical phenotypes including Silver syndrome (SS)/spastic paraplegia 17 (SPG17), distal hereditary motor neuropathy type V (dHMN-V), and Charcot-Marie-Tooth (CMT) disease type 2. We screened 407 Japanese patients who were clinically suspected of having CMT by exome sequencing and searched mutations in BSCL2. As a result, we identified five patients with heterozygous mutations in BSCL2. We confirmed three cases of known mutations (p.N88S and p.S90L) and two cases of novel mutations (p.N88T and p.S141A). The clinical features of the cases with known mutations in Japan were similar to those previously reported in other countries. In particular, there were many cases with sensory disturbance. The case with p.N88T mutation showed severe phenotype such as early onset age and prominent vocal cord paresis. The case with p.S141A mutation showed characteristics of demyelinating neuropathy such as CMT disease type 1 by electrophysiological examination. In this article, we report the clinical features and spread of cases with BSCL2 mutation in a Japanese cohort.Entities:
Keywords: zzm321990BSCL2; Charcot-Marie-Tooth disease; heterozygous mutation; sensory disturbance; vocal cord paresis
Mesh:
Substances:
Year: 2020 PMID: 32108980 DOI: 10.1111/jns.12369
Source DB: PubMed Journal: J Peripher Nerv Syst ISSN: 1085-9489 Impact factor: 3.494